May 15, 2013 ? Statins, the most widely prescribed drugs worldwide, are often suggested to lower cholesterol and prevent heart disease in individuals with obesity, diabetes and metabolic syndrome, which is a combination of medical disorders including excess body fat and/or high levels of blood pressure, blood sugar and/or cholesterol. However, University of Missouri researchers found that simvastatin, a generic type of statin previously sold under the brand name "Zocor," hindered the positive effects of exercise for obese and overweight adults.
"Fitness has proven to be the most significant predictor of longevity and health because it protects people from a variety of chronic diseases," said John Thyfault, an associate professor of nutrition and exercise physiology at MU. "Daily physical activity is needed to maintain or improve fitness, and thus improve health outcomes. However, if patients start exercising and taking statins at the same time, it seems that statins block the ability of exercise to improve their fitness levels."
Thyfault says many cardiologists want to prescribe statins to all patients over a certain age regardless of whether they have metabolic syndrome; the drugs also are recommended for people with Type 2 diabetes. He recommends that cardiologists more closely weigh the benefits and risks of statins given this new data about their effect on exercise training.
"Statins have only been used for about 15-20 years, so we don't know what the long-term effects of statins will be on aerobic fitness and overall health," Thyfault said. "If the drugs cause complications with improving or maintaining fitness, not everyone should be prescribed statins."
Thyfault and his colleagues measured cardiorespiratory fitness in 37 previously sedentary, obese individuals ages 25-59 with low fitness levels. The participants followed the same exercise regimen on the MU campus for 12 weeks; 18 of the 37 people also took 40 mg of simvastatin daily.
Statins significantly affected participants' exercise outcomes. Participants in the exercise-only group increased their cardiorespiratory fitness by an average of 10 percent compared to a 1.5 percent increase among participants also prescribed statins. Additionally, skeletal muscle mitochondrial content, the site where muscle cells turn oxygen into energy, decreased by 4.5 percent in the group taking statins while the exercise-only group had a 13 percent increase, a normal response following exercise training.
Thyfault suggests that future research determine whether lower doses of simvastatin or other types of statins similarly affect people's exercise outcomes and thus their risk for diseases such as Type 2 diabetes. Starting a statin regimen after exercising and obtaining a higher fitness level may reduce the drugs' effects on fitness, he says.
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by University of Missouri-Columbia. The original article was written by Kate McIntyre.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- Catherine R. Mikus, Leryn J. Boyle, Sarah J. Borengasser, Douglas J. Oberlin, Scott P. Naples, Justin Fletcher, Grace M. Meers, Meghan Ruebel, M. Harold Laughlin, Kevin C. Dellsperger, Paul J. Fadel, John P. Thyfault. Simvastatin impairs exercise training adaptations. Journal of the American College of Cardiology, 2013; DOI: 10.1016/j.jacc.2013.02.074
Note: If no author is given, the source is cited instead.
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/~3/HGgePthEP6g/130515151945.htm
Todd Akin Register To Vote Obama 2016 Who Is Winning The Election 2012 Election Coverage 2012 Linda McMahon Voting Results 2012
This week on techCrunch TV's Ask A VC show, we have Accel Partners' 
For the study, researchers surveyed a population of more than 130,000 women of reproductive age in Bangladesh using a pregnancy surveillance system established during the JiVitA-1 community-based maternal vitamin A or beta-carotene supplementation trial. The researchers prospectively recorded deaths among enrolled women. Employing a modified World Health Organization verbal autopsy method, physicians interviewed families at home about the events and circumstances leading up to the death of each woman. A separate set of physicians independently reviewed the verbal autopsies to ascertain the primary cause of death: 22 percent were related to pregnancy, 17 percent due to infection and 9 percent attributable to injuries (both unrelated to pregnancy), while 48 percent of the fatalities were assigned to non-communicable diseases, among which circulatory system diseases and cancer were the top causes.